Skip to content

Dengue virus rNS3pro immunization is associated with the expansion of regulatory-like T-cell phenotypes in BALB/c mice.

Aug 2026 · Acta Tropica · pp. 108306 · 0 citations · 32 references
Medicine

TL;DR

Dengue virus rNS3pro immunization drives a robust expansion of multifaceted regulatory-like T-cell phenotypes, identifying the NS3 protease domain as a potential player in DENV immune evasion strategies.

Abstract

Dengue virus (DENV) nonstructural protein 3 (NS3) is essential for viral replication and host immune evasion. While its protease domain (NS3pro) has been linked to T-cell anergy, its role in inducing regulatory T cells (Tregs) requires further exploration. To analyze the induction of diverse regulatory T-cell populations in BALB/c mice immunized with recombinant rNS3pro proteins from the four DENV serotypes. Mice were immunized with rNS3pro, and splenocytes were stimulated in vitro with homologous proteins. Cytokine expression and T-cell phenotypes-including markers for activation, exhaustion, and cytotoxicity-were analyzed via RT-PCR, ELISA, and flow cytometry. rNS3pro immunization induced a predominantly regulatory-associated response characterized by significant IL-10 expression. A marked expansion of CD4+CD25+ T cells (23.5% vs. 1.05% in controls) was observed, encompassing CD25+FoxP3+ regulatory-like T cells, alongside FoxP3-independent subsets expressing CD25+IL-10+ and CD25+TGF-β+. These cells co-expressed cytotoxicity-associated (FoxP3+Perforin+/GzB+) and co-inhibitory (CTLA-4+, PD-1+) markers. Effector CD8+ T-cell proliferation was significantly inhibited and could not be restored by exogenous IL-2. In conclusion, DENV rNS3pro immunization drives a robust expansion of multifaceted regulatory-like T-cell phenotypes. This immunomodulatory response correlates with compromised CD8+ effector proliferation, identifying the NS3 protease domain as a potential player in DENV immune evasion strategies.

View source

Similar papers

#protein folding Open access Oct 2026

A multi-epitope-based DNA vaccine confers cross-protection against influenza A H1N1 and H3N2 viruses

Background and Objectives: Influenza A virus remains a major global health concern because antigenic drift reduces the long-term efficacy of current vaccines. This study evaluated a multi-epitope DNA vaccine targeting conserved regions of hemagglutinin (HA) and polymerase acidic (PA) proteins from influenza A/H1N1 and...

K. Barkhordari, F. Rezaei, V. Salimi et al. · 0 citations

Design and immunogenicity study of a consensus dengue ns1 mRNA vaccine in mice

The findings demonstrate the feasibility of consensus-based NS1 antigen design for broad serotype coverage and support the further development of NS1-based immunogens as complementary components of next-generation dengue vaccines.

Kittipan Tharakhet · 0 citations
Aug 2026

BNT162b2 mRNA Vaccination Activates Spike-Reactive Regulatory T Cells in Humans.

Studies using mouse models of viral infection have shown that viral antigen-reactive regulatory T cells play multiple context-dependent roles, including attenuating the immune response against the pathogen and limiting inflammatory damage. By contrast, evidence for the presence and function of viral antigen-specific Tr...

Naila Shinwari, Xin-Xin Xue, Dong-Yun Lu et al. · 0 citations
Open access Aug 2026

Role of plasmacytoid dendritic cells in humoural and CD8+ T-cell memory responses following BNT162b2 mRNA vaccination: a preclinical mouse study

These findings identify pDCs as antigen-presenting cells involved in coordinating the immune response to BNT162b2, and pDCs appear to play a functional role in the efficacy of this mRNA vaccine.

C. Pizzichetti, I. Latino, T. Virgilio et al. · 0 citations
Open access Aug 2026

NLRC5 restricts Japanese encephalitis virus replication and neuroinflammation by interacting with the viral NS3 protein in an IFN-γ-dependent manner

It is demonstrated that NLRC5 functions as a cell-type-specific antiviral regulator during JEV infection and suppresses viral replication by directly binding to and degrading the viral NS3 protein in an LRR-dependent manner.

Prasanjit Jena, Rohit Soni, Abhigya Chhetri et al. · 0 citations
Open access Sep 2026

Conserved gammaherpesvirus protein kinase counters myeloid cell-specific type I IFN receptor but not IRF-3 expression to promote the establishment of chronic latent infection in the spleen

ABSTRACT Gammaherpesviruses are prevalent pathogens that are associated with cancers and autoimmune diseases. All gammaherpesviruses encode a conserved protein kinase. Expression of orf36, the protein kinase encoded by murine gammaherpesvirus 68 (MHV68), supports the establishment of a latent viral reservoir in splenic...

E. R. Johansen, M. A. Brown, X. G. Bradeen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.